Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for Symptomatic Uterine Fibroids
NCT03500367Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus in Uterine Fibroids (UF), leiomyomatosis, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
sirolimus
03
Conditions
Uterine Fibroids (UF)leiomyomatosis
Beyond the preview
Go deeper on NCT03500367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500367.